News | October 12, 2024
SIBUR to provide raw materials to Russian medical industry
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
We now rank 3rd in pharmaceutical production by volume and 14th by value
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Poor oral health (periodontal disease) impacts nearly 51% of Indians
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The net-zero target approval complements the company's near-term emission reduction targets
Developed in consultation with clinicians and patients for an enhanced user experience
India has taken the lead in recognising NAFLD as a major non-communicable disease
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
Subscribe To Our Newsletter & Stay Updated
